PERKUTAN KORONAR ARALASHUVDAN KEYIN BEMORNI KOMPLEKS TERAPEVTIK BOSHQARISH: ANTITROMBOTIK DAVOLASH, LIPID NAZORATI VA ARTERIAL BOSIMNI OPTIMALLASHTIRISH
;
perkutan koronar aralashuv, stent, ikki komponentli antiagregant terapiya, surunkali koronar sindrom, o’tkir koronar sindrom, LDL-xolesterin, arterial gipertenziya, terapiya, intervension kardiologiya.Abstrak
Perkutan koronar aralashuv (PKA, PCI) koronar arteriya kasalligini davolashda eng ko’p qo’llaniladigan invaziv usullardan biri bo’lsa-da, stent qo’yilishi kasallikning yakuniy nuqtasi emas. Klinik natija ko’p jihatdan stentdan keyingi terapevtik boshqaruvga - antitrombotik davo davomiyligini individual tanlash, qon ketish va ishemik xavfni muvozanatlash, past zichlikdagi lipoprotein xolesterinni (LDL-X) maqsadli darajaga tushirish, arterial bosimni barqaror nazorat qilish, qandli diabet va surunkali buyrak kasalligini bir vaqtda boshqarishga bog’liq. Ushbu maqolada 2023-2025-yillarda e’lon qilingan yirik klinik ko’rsatmalar asosida PKA o’tkazilgan bemorlarni terapevtik kuzatishning amaliy algoritmi taklif etiladi. Maqola terapiya shifokori, kardiolog, intervension kardiolog va oilaviy shifokor o’rtasidagi uzluksiz hamkorlikka urg’u beradi. Asosiy g’oya shundan iboratki, yaxshi bajarilgan stentlash natijasi faqat angiografik muvaffaqiyat bilan emas, balki keyingi 12 oy va undan uzoq davrda dori qabul qilish intizomi, laborator nazorat va xavf omillarini agressiv korreksiya qilish bilan belgilanadi.
Iqtiboslar
Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal. 2024;45(36):3415-3537. doi:10.1093/eurheartj/ehae177.
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;44(38):3720-3826. doi:10.1093/eurheartj/ehad191.
McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. 2024;45(38):3912-4018. doi:10.1093/eurheartj/ehae178.
Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Circulation. 2025;152(11):e114-e218. doi:10.1161/CIR.0000000000001356.
Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. Journal of the American College of Cardiology. 2022;79(2):e21-e129. doi:10.1016/j.jacc.2021.09.006.
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455.
Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2021;42(34):3227-3337. doi:10.1093/eurheartj/ehab484.
Urban P, Mehran R, Colleran R, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. European Heart Journal. 2019;40(31):2632-2653. doi:10.1093/eurheartj/ehz372.
Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease. European Heart Journal. 2018;39(3):213-260. doi:10.1093/eurheartj/ehx419.
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021;42(14):1289-1367. doi:10.1093/eurheartj/ehaa575.
##submission.downloads##
Nashr qilingan
Nashr
Bo'lim
Iqtibos keltirish tartibi
